One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,
Australasia,Asia,Middle East,Africa
Monthly Production Capacity: hundreds of grams
Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag
Delivery Lead Time: In stock or 2-3weeks
Sample Provided: yes
Payment Terms: T/T
LSKL is an inhibitor peptide composed of 4 amino acids. It is a peptide derived from a latency-related peptide, which can inhibit the activation of TGF-β thrombospondin (TSP-1) and prevent liver damage and fibrosis; at the same time, LSKL It can easily cross the blood-brain barrier and reduce hydrocephalus; LSKL can successfully reduce the activation of TGF-β-Smad signal by antagonizing TSP-1, but cannot reduce the protein expression of TSP-1; LSKL can also promote liver after hepatectomy Cell Proliferation.
Audited Supplier
Pharma Sources Insight January 2025
